Ocuphire Pharma, Inc. /
Opus Genetics Inc.
Ocuphire Pharma combines with Opus Genetics Inc.
What happened
Ocuphire Pharma, Inc. completed its business combination with Opus Genetics Inc. on Oct. 22, 2024.
As part of the transaction, Ocuphire issued shares of its common stock and preferred stock to Opus securityholders.
The source
Everything on this page comes from the source below.
Ocuphire Pharma combines with Opus Genetics Inc.
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly